Cargando…
Comparison of Anti-oncotic Effect of TRPM4 Blocking Antibody in Neuron, Astrocyte and Vascular Endothelial Cell Under Hypoxia
In stroke and other neurological diseases, Transient Receptor Potential Melastatin 4 (TRPM4) has been reported to cause oncotic cell death which is due to an excessive influx of sodium ions. Following stroke, hypoxia condition activates TRPM4 channel, and the sodium influx via TRPM4 is further enhan...
Autores principales: | Wei, Shunhui, Low, See Wee, Poore, Charlene Priscilla, Chen, Bo, Gao, Yahui, Nilius, Bernd, Liao, Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7604339/ https://www.ncbi.nlm.nih.gov/pubmed/33195194 http://dx.doi.org/10.3389/fcell.2020.562584 |
Ejemplares similares
-
SLC26A11 Inhibition Reduces Oncotic Neuronal Death and Attenuates Stroke Reperfusion Injury
por: Wei, Shunhui, et al.
Publicado: (2023) -
TRPM4 Blocking Antibody Protects Cerebral Vasculature in Delayed Stroke Reperfusion
por: Chen, Bo, et al.
Publicado: (2023) -
Binding epitope for recognition of human TRPM4 channel by monoclonal antibody M4M
por: Wei, Shunhui, et al.
Publicado: (2022) -
Development and characterization of a monoclonal antibody blocking human TRPM4 channel
por: Low, See Wee, et al.
Publicado: (2021) -
TRPM4-specific blocking antibody attenuates reperfusion injury in a rat model of stroke
por: Chen, Bo, et al.
Publicado: (2019)